Table 1 Clinical characteristics of the study cohort.

From: The distribution and the relationship of HPV subtypes infection with pregnancy outcomes

Variables

Total

(n = 7110)

HPV infection

p

Control

(n = 5690)

I

(n = 216)

II

(n = 655)

III

(n = 414)

IV

(n = 135)

Maternal age (years)

31.1 ± 4.3

31.2 ± 4.2

30.7 ± 4.6

30.7 ± 4.2

31.0 ± 4.7

30.3 ± 4.6

0.005

Gravidity n (%)

1

2753 (38.7)

2183 (38.4)

96 (44.7)

258 (39.4)

157 (37.9)

59 (43.7)

0.148

2

2160 (30.4)

1771 (31.1)

54 (25.1)

179 (27.3)

117 (28.3)

39 (28.9)

3

2195 (30.9)

1735 (30.5)

65 (30.2)

218 (33.3)

140 (33.8)

37 (27.4)

Parity n (%)

0–1

4271 (60.1)

3396 (59.7)

140 (64.8)

402 (61.4)

250 (60.4)

83 (61.5)

0.562

2

2839 (39.9)

2294 (40.3)

76 (35.2)

253 (38.6)

164 (39.6)

52 (38.5)

Baby sex n (%)

Male

3716 (52.3)

3020 (53.1)

103 (47.7)

314 (47.9)

205 (49.5)

74 (54.8)

0.043

Female

3394 (47.7)

2670 (46.9)

113 (52.3)

341 (52.1)

209 (50.5)

61 (45.2)

GA at delivery (weeks)

38.6 ± 2.1

38.6 ± 2.1

38.7 ± 2.0

38.5 ± 2.3

38.6 ± 2.4

38.8 ± 1.9

0.313

Birth weight (g)

3237.9 ± 516.5

3239.1 ± 513.8

3195.9 ± 488.8

3215.3 ± 540.1

3267.6 ± 527.0

3269.9 ± 523.0

0.330

Baby height (cm)

49.3 ± 2.6

49.3 ± 2.6

49.1 ± 2.8

49.1 ± 2.7

49.3 ± 3.0

49.4 ± 2.2

0.514